Aspen Grove Capital LLC Cuts Holdings in VanEck Pharmaceutical ETF $PPH

Aspen Grove Capital LLC decreased its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 28.7% in the first quarter, Holdings Channel reports. The firm owned 18,676 shares of the company’s stock after selling 7,533 shares during the quarter. Aspen Grove Capital LLC’s holdings in VanEck Pharmaceutical ETF were worth $1,940,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of PPH. Banque Cantonale Vaudoise lifted its position in VanEck Pharmaceutical ETF by 6.4% during the first quarter. Banque Cantonale Vaudoise now owns 1,907 shares of the company’s stock valued at $198,000 after purchasing an additional 115 shares during the period. CWM LLC lifted its holdings in VanEck Pharmaceutical ETF by 36.3% in the fourth quarter. CWM LLC now owns 511 shares of the company’s stock valued at $53,000 after acquiring an additional 136 shares during the period. IFP Advisors Inc lifted its holdings in VanEck Pharmaceutical ETF by 53.7% in the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock valued at $40,000 after acquiring an additional 153 shares during the period. Farther Finance Advisors LLC boosted its position in VanEck Pharmaceutical ETF by 64.7% in the fourth quarter. Farther Finance Advisors LLC now owns 718 shares of the company’s stock worth $74,000 after purchasing an additional 282 shares during the last quarter. Finally, AlphaCore Capital LLC purchased a new position in VanEck Pharmaceutical ETF in the fourth quarter worth about $31,000.

VanEck Pharmaceutical ETF Stock Up 1.2%

VanEck Pharmaceutical ETF stock opened at $109.95 on Friday. VanEck Pharmaceutical ETF has a 52-week low of $81.74 and a 52-week high of $112.58. The company has a market cap of $938.97 million, a P/E ratio of 20.21 and a beta of 0.46. The business has a 50-day simple moving average of $106.34 and a two-hundred day simple moving average of $105.61.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 7th. Shareholders of record on Wednesday, July 1st were given a $0.6248 dividend. The ex-dividend date was Wednesday, July 1st. This represents a $2.50 annualized dividend and a yield of 2.3%.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.